Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01668342 · ClinicalTrials.gov registry record · Phase 1
Mobile Phone Text Message Program to Understand Symptoms and Improve Outcomes in Minor Head Injury Patients
A Phase 1 study of Head Injury, Minor, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 1
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT01668342: Completed Phase 1 study of Head Injury, Minor, sponsored by University of Pittsburgh.
NCT01668342 is a Phase 1 study of Head Injury, Minor that has completed, run by University of Pittsburgh. The registered enrollment target is 45 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (25% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01668342, a Phase 1 study of Head Injury, Minor, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
Mild traumatic brain injury (MTBI) is frequently seen in the ED, post-concussive symptoms are common post-injury, and few MTBI patients receive treatment or follow-up for these symptoms. Cell phones are ubiquitous, text messaging (SMS) is a cheap and increasingly common form of communication, potentially allowing for accurate assessment of symptom patterns after MTBI and provision of basic education support . The investigators seek to assess the feasibility of using SMS to collect symptoms related to MTBI in patients either discharged from the ED or admitted to the inpatient trauma unit. The investigators also seek to explore how SMS-based symptom reports correlate with phone-based follow-up reports at 14 days and whether additional SMS-based educational feedback alters daily symptom patterns.
Conditions Studied
Interventions
- BEHAVIORAL SMS assessments & feedback
Study Locations (1)
Pennsylvania
- University of Pittsburgh Medical Center-Mercy Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2012-06 |
| Est. Completion | 2013-09 |
| Phase | Phase 1 |
What the finished NCT01668342 record still lists
NCT01668342 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (25% lower).
The record links to 1 condition, with Head Injury, Minor appearing as the primary indexed condition, and to 1 intervention - of which SMS assessments & feedback is the first listed.
NCT01668342 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01668342 about?
NCT01668342 is a clinical study titled "Mobile Phone Text Message Program to Understand Symptoms and Improve Outcomes in Minor Head Injury Patients". Mild traumatic brain injury (MTBI) is frequently seen in the ED, post-concussive symptoms are common post-injury, and few MTBI patients receive treatment or follow-up for these symptoms. Cell phones are ubiquitous, text messaging (SMS) is a cheap and increasingly common form of communication, potent...
What is the current status of trial NCT01668342?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 45 participants. The study started on 2012-06. Estimated completion is 2013-09.
What conditions does trial NCT01668342 study?
This clinical trial studies the following conditions: Head Injury, Minor.
What interventions are being tested in trial NCT01668342?
The interventions under investigation include: SMS assessments & feedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT01668342?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01668342 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head Injury, Minor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01668342's enrollment target sits among peer trials
45 1066th of 2000 higher than 915 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia